Fibrocell Science, Inc., an autologous cell and gene therapy company, focuses on treatments for skin and connective tissue diseases. The Company is developing an autologous fibroblast therapy for chronic dysphonia. Fibrocell's gene-therapy program uses gene-modified autologous fibroblasts to treat RDEB. The Company also has a gene-therapy program for linear scleroderma.
405 Eagleview Blvd.
Exton, PA 19341